1-17 of 17
Kwame Osei
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

James R. Gavin III, MD, PhD—A Humble and Remarkable Trailblazer, Scientist, Advocate, Mentor, and Educator for Diabetes

Kwame Osei, Sherita Hill Golden
Journal: Diabetes Care
Diabetes Care 2015;38(6):963–967
https://doi.org/10.2337/dc14-3035
Published: 12 May 2015
View article titled, James R. Gavin III, MD, PhD—A Humble and Remarkable Trailblazer, Scientist, Advocate, Mentor, and Educator for Diabetes
Open the PDF for James R. Gavin III, MD, PhD—A Humble and Remarkable Trailblazer, Scientist, Advocate, Mentor, and Educator for Diabetes in another window
Journal Articles

Comparative Study of Glucose Homeostasis, Lipids and Lipoproteins, HDL Functionality, and Cardiometabolic Parameters in Modestly Severely Obese African Americans and White Americans With Prediabetes: Implications for the Metabolic Paradoxes

Sara J. Healy, Kwame Osei, Trudy Gaillard
Journal: Diabetes Care
Diabetes Care 2015;38(2):228–235
https://doi.org/10.2337/dc14-1803
Published: 18 December 2014
View article titled, Comparative Study of Glucose Homeostasis, Lipids and Lipoproteins, HDL Functionality, and Cardiometabolic Parameters in Modestly Severely Obese African Americans and White Americans With Prediabetes: Implications for the Metabolic Paradoxes
Open the PDF for Comparative Study of Glucose Homeostasis, Lipids and Lipoproteins, HDL Functionality, and Cardiometabolic Parameters in Modestly Severely Obese African Americans and White Americans With Prediabetes: Implications for the Metabolic Paradoxes in another window
Journal Articles

Prandial Insulin Dosing Using the Carbohydrate Counting Technique in Hospitalized Patients With Type 2 Diabetes

Kathleen M. Dungan, MD, Colleen Sagrilla, BS, Mahmoud Abdel-Rasoul, MS, Kwame Osei, MD
Journal: Diabetes Care
Diabetes Care 2013;36(11):3476–3482
https://doi.org/10.2337/dc13-0121
Published: 15 October 2013
View article titled, Prandial Insulin Dosing Using the Carbohydrate Counting Technique in Hospitalized Patients With Type 2 Diabetes
Open the PDF for Prandial Insulin Dosing Using the Carbohydrate Counting Technique in Hospitalized Patients With Type 2 Diabetes in another window
Journal Articles

Response to Comment on: Gaillard et al. HDL Dysfunctionality (Paraoxonase) Is Worse in Nondiabetic, Postmenopausal African American Than in White Women. Diabetes Care 2011;34:e19

Trudy Gaillard, RN, PHD, Sampath Parthasarathy, PHD, MBA, Kwame Osei, MD
Journal: Diabetes Care
Diabetes Care 2011;34(9):e151
https://doi.org/10.2337/dc11-1176
Published: 19 August 2011
View article titled, Response to Comment on: Gaillard et al. HDL Dysfunctionality (Paraoxonase) Is Worse in Nondiabetic, Postmenopausal African American Than in White Women. Diabetes Care 2011;34:e19
Open the PDF for Response to Comment on: Gaillard et al. HDL Dysfunctionality (Paraoxonase) Is Worse in Nondiabetic, Postmenopausal African American Than in White Women. Diabetes Care 2011;34:e19 in another window
Journal Articles

HDL Dysfunctionality (Paraoxonase) Is Worse in Nondiabetic, Postmenopausal African American Than in White Women

Trudy Gaillard, RN, PHD, Sampath Parthasarathy, PHD, MBA, Kwame Osei, MD
Journal: Diabetes Care
Diabetes Care 2011;34(2):e19
https://doi.org/10.2337/dc10-1189
Published: 20 January 2011
View article titled, HDL Dysfunctionality (Paraoxonase) Is Worse in Nondiabetic, Postmenopausal African American Than in White Women
Open the PDF for HDL Dysfunctionality (Paraoxonase) Is Worse in Nondiabetic, Postmenopausal African American Than in White Women in another window
Journal Articles

Ragaglitazar Improves Glycemic Control and Lipid Profile in Type 2 Diabetic Subjects: A 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm

Mohammed F. Saad, MD, Susan Greco, MD, Kwame Osei, MD, Andrew J. Lewin, MD, Christopher Edwards, MD, Margarita Nunez, MD, Rickey R. Reinhardt, MD, for the Ragaglitazar Dose-Ranging Study Group
Journal: Diabetes Care
Diabetes Care 2004;27(6):1324–1329
https://doi.org/10.2337/diacare.27.6.1324
Published: 01 June 2004
View article titled, Ragaglitazar Improves Glycemic Control and Lipid Profile in Type 2 Diabetic Subjects: <subtitle>A 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm </subtitle>
Open the PDF for Ragaglitazar Improves Glycemic Control and Lipid Profile in Type 2 Diabetic Subjects: <subtitle>A 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm </subtitle> in another window
Journal Articles

Impaired Insulin Sensitivity, Insulin Secretion, and Glucose Effectiveness Predict Future Development of Impaired Glucose Tolerance and Type 2 Diabetes in Pre-Diabetic African Americans: Implications for primary diabetes prevention

Kwame Osei, MD, Scott Rhinesmith, MD, Trudy Gaillard, RN, CDE, Dara Schuster, MD
Journal: Diabetes Care
Diabetes Care 2004;27(6):1439–1446
https://doi.org/10.2337/diacare.27.6.1439
Published: 01 June 2004
View article titled, Impaired Insulin Sensitivity, Insulin Secretion, and Glucose Effectiveness Predict Future Development of Impaired Glucose Tolerance and Type 2 Diabetes in Pre-Diabetic African Americans: <subtitle>Implications for primary diabetes prevention</subtitle>
Open the PDF for Impaired Insulin Sensitivity, Insulin Secretion, and Glucose Effectiveness Predict Future Development of Impaired Glucose Tolerance and Type 2 Diabetes in Pre-Diabetic African Americans: <subtitle>Implications for primary diabetes prevention</subtitle> in another window
Journal Articles

History of Gestational Diabetes Leads to Distinct Metabolic Alterations in Nondiabetic African-American Women With a Parental History of Type 2 Diabetes

Kwame Osei, MD, Trudy R Gaillard, RN, MS, CDE, Dara P Schuster, MD
Journal: Diabetes Care
Diabetes Care 1998;21(8):1250–1257
https://doi.org/10.2337/diacare.21.8.1250
Published: 01 August 1998
View article titled, History of Gestational Diabetes Leads to Distinct Metabolic Alterations in Nondiabetic African-American Women With a Parental History of Type 2 Diabetes
Open the PDF for History of Gestational Diabetes Leads to Distinct Metabolic Alterations in Nondiabetic African-American Women With a Parental History of Type 2 Diabetes in another window
Journal Articles

The Impact of Socioeconomic Status on Cardiovascular Risk Factors in African-Americans at High Risk for Type II Diabetes: Implications for syndrome X

Trudy R Gaillard, RN, MS, CDE, Dara P Schuster, MD, Brenda M Bossetti, RD, CDE, PHD, Patricia A Green, RD, CDE, Kwame Osei, MD
Journal: Diabetes Care
Diabetes Care 1997;20(5):745–752
https://doi.org/10.2337/diacare.20.5.745
Published: 01 May 1997
View article titled, The Impact of Socioeconomic Status on Cardiovascular Risk Factors in African-Americans at High Risk for Type II Diabetes: Implications for syndrome X
Open the PDF for The Impact of Socioeconomic Status on Cardiovascular Risk Factors in African-Americans at High Risk for Type II Diabetes: Implications for syndrome X in another window
Journal Articles

Pathogenetic Mechanisms of Impaired Glucose Tolerance and Type II Diabetes in African-Americans: The significance of insulin secretion, insulin sensitivity, and glucose effectiveness

Kwame Osei, MD, Trudy Gaillard, RN, MS, CDE, Dara P Schuster, MD
Journal: Diabetes Care
Diabetes Care 1997;20(3):396–404
https://doi.org/10.2337/diacare.20.3.396
Published: 01 March 1997
View article titled, Pathogenetic Mechanisms of Impaired Glucose Tolerance and Type II Diabetes in African-Americans: The significance of insulin secretion, insulin sensitivity, and glucose effectiveness
Open the PDF for Pathogenetic Mechanisms of Impaired Glucose Tolerance and Type II Diabetes in African-Americans: The significance of insulin secretion, insulin sensitivity, and glucose effectiveness in another window
Journal Articles

Serum Insulin and Glucose Concentrations in People at Risk for Type II Diabetes: A comparative study of African Americans and Nigerians

Kwame Osei, MD, Daryl A Cottrell, MD, Christopher A Adenuwon, PHD, Ernest C Ezenwaka, MS, Abayomi O Akanji, MD, PHD, Thomas M O'Dorisio, MD
Journal: Diabetes Care
Diabetes Care 1993;16(10):1367–1375
https://doi.org/10.2337/diacare.16.10.1367
Published: 01 October 1993
View article titled, Serum Insulin and Glucose Concentrations in People at Risk for Type II Diabetes: A comparative study of African Americans and Nigerians
Open the PDF for Serum Insulin and Glucose Concentrations in People at Risk for Type II Diabetes: A comparative study of African Americans and Nigerians in another window
Journal Articles

Hypoglycemia After Successful Pancreas Transplantation in Type I Diabetic Patients

Daryl A Cottrell, MD, Mitchell l Henry, MD, Thomas M O'Dorisio, MD, Raymond J Tesi, MD, Ronald M Ferguson, MD, Kwame Osei, MD
Journal: Diabetes Care
Diabetes Care 1991;14(11):1111–1112
https://doi.org/10.2337/diacare.14.11.1111
Published: 01 November 1991
View article titled, Hypoglycemia After Successful Pancreas Transplantation in Type I Diabetic Patients
Open the PDF for Hypoglycemia After Successful Pancreas Transplantation in Type I Diabetic Patients in another window
Journal Articles

Insulin Sensitivity, Glucose Effectiveness, and Body Fat Distribution Pattern in Nondiabetic Offspring of Patients With NIDDM

Kwame Osei, MD, Daryl A Cottrell, MD, Martha M Orabella, RD
Journal: Diabetes Care
Diabetes Care 1991;14(10):890–896
https://doi.org/10.2337/diacare.14.10.890
Published: 01 October 1991
View article titled, Insulin Sensitivity, Glucose Effectiveness, and Body Fat Distribution Pattern in Nondiabetic Offspring of Patients With NIDDM
Open the PDF for Insulin Sensitivity, Glucose Effectiveness, and Body Fat Distribution Pattern in Nondiabetic Offspring of Patients With NIDDM in another window
Journal Articles

Decreased Serum C-Peptide/Insulin Molar Ratios: A Reply

Kwame Osei, M.D., James M Falko, M.D., Thomas M O'Dorisio, M.D., David R Adam, B.S.
Journal: Diabetes Care
Diabetes Care 1985;8(5):524–525
https://doi.org/10.2337/diacare.8.5.524b
Published: 01 September 1985
View article titled, Decreased Serum C-Peptide/Insulin Molar Ratios: A Reply
Open the PDF for Decreased Serum C-Peptide/Insulin Molar Ratios: A Reply in another window
Journal Articles

Gastric Inhibitory Polypeptide (GIP) Responses After Oral Glucose Ingestion in Hyperthyroidism

Kwame Osei, M.D., James M Falko, M.D., Thomas M O'Dorisio, M.D., David R Adam, B.Sc.
Journal: Diabetes Care
Diabetes Care 1985;8(5):436–439
https://doi.org/10.2337/diacare.8.5.436
Published: 01 September 1985
View article titled, Gastric Inhibitory Polypeptide (GIP) Responses After Oral Glucose Ingestion in Hyperthyroidism
Open the PDF for Gastric Inhibitory Polypeptide (GIP) Responses After Oral Glucose Ingestion in Hyperthyroidism in another window
Journal Articles

Decreased Serum C-Peptide/Insulin Molar Ratios After Oral Glucose Ingestion in Hyperthyroid Patients

Kwame Osei, M.D., James M Falko, M.D., Thomas M O'Dorisio, M.D., David R Adam, B.S.
Journal: Diabetes Care
Diabetes Care 1984;7(5):471–475
https://doi.org/10.2337/diacare.7.5.471
Published: 01 September 1984
View article titled, Decreased Serum C-Peptide/Insulin Molar Ratios After Oral Glucose Ingestion in Hyperthyroid Patients
Open the PDF for Decreased Serum C-Peptide/Insulin Molar Ratios After Oral Glucose Ingestion in Hyperthyroid Patients in another window
Journal Articles

Significance of Spontaneous Ketonuria and Serum C-Peptide Levels in Obese Type II Diabetic Patients

Kwame Osei, M.D., James M Falko, M.D., Thomas M O'Dorisio, M.D., David R Adam, B.S., Samuel Cataland, M.D.
Journal: Diabetes Care
Diabetes Care 1984;7(5):442–446
https://doi.org/10.2337/diacare.7.5.442
Published: 01 September 1984
View article titled, Significance of Spontaneous Ketonuria and Serum C-Peptide Levels in Obese Type II Diabetic Patients
Open the PDF for Significance of Spontaneous Ketonuria and Serum C-Peptide Levels in Obese Type II Diabetic Patients in another window